Joshua L. Smiley
Chief Financial Officer, Eli Lilly and Company.
Companies
- Zai Lab LimitedOfficer Apr 5, 2023 to now1
- Zai Lab LimitedChief operating officer Aug 3, 2022 to Aug 16, 20222
- Eli Lilly and CompanyChief financial officer Jan 10, 2018 to Feb 3, 20213
- ElancoBoard member Sep 19, 2018 to Sep 19, 20184
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Eli Lilly and Company LLY79,810 shares5$100.3M at $1,257.32Feb 10, 2021- Zai Lab Limited ZLAB117,602 shares6$2.8M at $24.01Apr 6, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 6, 2026Sold 3,017 shares at $20.45 of Zai Lab Limited6
- Apr 2, 2026Sold 9,614 shares at $20.39 of Zai Lab Limited7
- Apr 2, 2026Exercised options 7,145 shares of Zai Lab Limited7
- Apr 1, 2026Exercised options 32,062 shares of Zai Lab Limited7
- Mar 13, 2026Sold 1,966 shares at $18.63 of Zai Lab Limited8
- Mar 12, 2026Exercised options 6,388 shares of Zai Lab Limited8
- Sep 10, 2025Bought 10,000 shares at $28.91 of Zai Lab Limited9
- Aug 18, 2025Sold 6,641 shares at $36.24 of Zai Lab Limited10
- Aug 15, 2025Exercised options 15,900 shares of Zai Lab Limited10
- Apr 4, 2025Sold 3,354 shares at $33.11 of Zai Lab Limited11
- Apr 3, 2025Exercised options 7,145 shares of Zai Lab Limited11
- Apr 2, 2025Sold 11,740 shares at $35.89 of Zai Lab Limited12
- Apr 1, 2025Exercised options 32,062 shares of Zai Lab Limited12
- Aug 16, 2024Sold 4,352 shares at $16.67 of Zai Lab Limited13
- Aug 15, 2024Exercised options 15,900 shares of Zai Lab Limited13
- May 13, 2024Bought 3,000 shares at $21.40 of Zai Lab Limited14
- Apr 4, 2024Sold 1,988 shares at $15.67 of Zai Lab Limited15
- Apr 3, 2024Exercised options 7,145 shares at $15.90 of Zai Lab Limited15
- Mar 1, 2024Bought 3,000 shares at $20.83 of Zai Lab Limited16
- Dec 14, 2023Bought 4,000 shares at $29.90 of Zai Lab Limited17
- Nov 16, 2023Bought 5,000 shares at $26.93 of Zai Lab Limited18
- Aug 15, 2023Shares withheld for tax 4,373 shares at $24.52 of Zai Lab Limited19
- Aug 15, 2023Exercised options 15,900 shares of Zai Lab Limited19
- Feb 8, 2021Granted 25,409 shares at $205.77 of Eli Lilly and Company5
- Feb 1, 2021Shares withheld for tax 8,452 shares at $207.97 of Eli Lilly and Company20
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Oct 25, 2019 | LLY | Buy | $100.0K | +1035.8% | +879.9% | +16.1% |
| Jul 15, 2019 | LLY | Buy | $20.1K | +1053.9% | +897.3% | +45.0% |
| Jun 5, 2019 | LLY | Buy | $50.3K | +969.6% | +796.8% | +18.8% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARZai Lab Limited, Officer
- 2
- 3
- 4SEC EDGARElanco, Board member
- 5
- 6
- 7SEC EDGARForm 4 filed Apr 3, 2026
- 8SEC EDGARForm 4 filed Mar 16, 2026
- 9SEC EDGARForm 4 filed Sep 12, 2025
- 10SEC EDGARForm 4 filed Aug 19, 2025
- 11SEC EDGARForm 4 filed Apr 7, 2025
- 12SEC EDGARForm 4 filed Apr 3, 2025
- 13SEC EDGARForm 4 filed Aug 19, 2024
- 14SEC EDGARForm 4 filed May 15, 2024
- 15SEC EDGARForm 4 filed Apr 5, 2024
- 16SEC EDGARForm 4 filed Mar 4, 2024
- 17SEC EDGARForm 4 filed Dec 18, 2023
- 18SEC EDGARForm 4 filed Nov 16, 2023
- 19SEC EDGARForm 4 filed Aug 17, 2023
- 20SEC EDGARForm 4 filed Feb 3, 2021